https://www.selleckchem.com/pr....oducts/carfilzomib-p
The prevalence of obesity observed in treated ADHD patients was significantly lower compared to that in unmedicated patients. This result suggests that the treatment is not only important for controlling ADHD manifestations but is also associated with lower body mass index. Therefore, further prospective studies with large sample size are required for controlling the confounding factors such as comorbidities and medication status. The prevalence of obesity observed in treated ADHD patients was significantly lower compared to